The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Organics Limited, a member of the promoter group of Valiant Laboratories Limited, is proposing to acquire 1,86,07,531 equity shares (34.26% of share capital) from Dhanvallabh Ventures LLP through an off-market transaction. This is part of a restructuring exercise being undertaken by Valiant Organics. The 60-day volume weighted average market price is Rs. 62.71 per share, and the acquisition price will not exceed the regulatory limits. Post-transaction, Valiant Organics will hold 34.26% while Dhanvallabh Ventures' stake will reduce from 46.84% to 12.58%.
This acquisition increases promoter group holding in Valiant Laboratories, consolidating shares within the promoter group. The significant 34.26% stake transfer indicates restructuring rather than a new entrant, which may be viewed positively if it strengthens promoter commitment.